Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Cancer Res ; 66(14): 7211-5, 2006 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-16849568

RESUMEN

Angiostatin4.5 (AS4.5) is the product of plasmin autoproteolysis and consists of kringles 1 to 4 and approximately 85% of kringle 5. In culture, cancer cell surface globular beta-actin mediates plasmin autoproteolysis to AS4.5. We now show that plasminogen binds to prostate cancer cells and that the binding colocalizes with surface beta-actin, but AS4.5 does not bind to the cell surface. Plasminogen and plasmin bind to immobilized beta-actin similarly, with a Kd of approximately 140 nmol/L. The binding is inhibited by epsilon-aminocaproic acid (epsilonACA), indicating the requirement for a lysine-kringle domain interaction. Using a series of peptides derived from beta-actin in competitive binding studies, we show that the domain necessary for plasminogen binding is within amino acids 55 to 69 (GDEAQSKRGILTLKY). Substitution of Lys61 or Lys68 with arginine results in the loss of the ability of the peptide to block plasminogen binding, indicating that Lys61 and Lys68 are essential for plasminogen binding. Other actin peptides, including peptides with lysine, did not inhibit the plasminogen-actin interaction. AS4.5 did not bind actin at concentrations up to 40 micromol/L. Plasminogen, plasmin, and AS4.5 all contain kringles 1 to 4; however, kringle 5 is truncated in AS4.5. Isolated kringle 5 binds to actin, suggesting intact kringle 5 is necessary for plasminogen and plasmin to bind to cell surface beta-actin, and the truncated kringle 5 in AS4.5 results in its release from beta-actin. These data may explain the mechanism by which AS4.5 is formed locally on cancer cell surfaces and yet acts on distant sites.


Asunto(s)
Actinas/metabolismo , Angiostatinas/metabolismo , Fibrinolisina/metabolismo , Plasminógeno/metabolismo , Neoplasias de la Próstata/irrigación sanguínea , Neoplasias de la Próstata/metabolismo , Secuencia de Aminoácidos , Línea Celular Tumoral , Membrana Celular/metabolismo , Ensayo de Inmunoadsorción Enzimática , Humanos , Masculino , Modelos Moleculares , Datos de Secuencia Molecular , Neovascularización Patológica/metabolismo , Fragmentos de Péptidos/metabolismo , Unión Proteica
2.
J Histochem Cytochem ; 54(6): 665-72, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16714422

RESUMEN

Two epithelial cell types cover the alveolar surface of the lung. Type II alveolar epithelial cells produce surfactant and, during development or following wounding, give rise to type I cells that are involved in gas exchange and alveolar fluid homeostasis. In culture, freshly isolated alveolar type II cells assume a more squamous (type I-like) appearance within 4 days after plating. They assemble numerous focal adhesions that associate with the actin cytoskeleton at the cell margins. These alveolar epithelial cells lose expression of type II cell markers including SP-C and after 4 days in culture express the type I cell marker T1alpha. Those cells that express T1alpha also deposit fibers of laminin-311 in their matrix. The latter appears to be related to their development of a type I phenotype because freshly isolated, primary type I cells also assemble laminin-311-rich fibers in vitro. A beta1 integrin antibody antagonist inhibits the assembly of laminin-311 matrix fibers. Moreover, the formation of laminin fibers is dependent on the activity of the small GTPases and is perturbed by ML-7, a myosin light chain kinase inhibitor. In summary, our data indicate that assembly of laminin-311 fibers by lung epithelial cells is integrin and actin cytoskeleton dependent, and that these fibers are characteristic of type I alveolar cells.


Asunto(s)
Laminina/metabolismo , Alveolos Pulmonares/metabolismo , Mucosa Respiratoria/metabolismo , Citoesqueleto de Actina/ultraestructura , Actinas/fisiología , Animales , Azepinas/farmacología , Células Cultivadas , Citoesqueleto/fisiología , Electroforesis en Gel de Poliacrilamida , Matriz Extracelular/metabolismo , Matriz Extracelular/ultraestructura , Immunoblotting , Integrina beta1/fisiología , Laminina/ultraestructura , Masculino , Glicoproteínas de Membrana/metabolismo , Microscopía Fluorescente , Proteínas de Unión al GTP Monoméricas/metabolismo , Quinasa de Cadena Ligera de Miosina/antagonistas & inhibidores , Miosinas/fisiología , Naftalenos/farmacología , Alveolos Pulmonares/citología , Alveolos Pulmonares/ultraestructura , Ratas , Ratas Sprague-Dawley , Mucosa Respiratoria/citología , Mucosa Respiratoria/ultraestructura
3.
J Biol Chem ; 281(29): 19892-8, 2006 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-16636055

RESUMEN

Hypoxia has been shown to cause lung edema and impair lung edema clearance. In the present study, we exposed isolated rat lungs to pO(2) = 40 mm Hg for 60 min or rats to 8% O(2) for up to 24 h and then measured changes in alveolar fluid reabsorption (AFR) and Na,K-ATPase function. Low levels of oxygen severely impaired AFR in both ex vivo and in vivo models. The decrease in AFR was associated with a decrease in Na,K-ATPase activity and protein abundance in the basolateral membranes from peripheral lung tissue of hypoxic rats. Beta-adrenergic agonists restored AFR in rats exposed to 8% O(2) (from 0.02 +/- 0.07 ml/h to 0.59 +/- 0.03 ml/h), which was associated with parallel increases in Na,K-ATPase protein abundance in the basolateral membrane. Hypoxia is associated with increased production of reactive oxygen species. Therefore, we examined whether overexpression of SOD2, manganese superoxide dismutase, would prevent the hypoxia-mediated decrease in AFR. Spontaneously breathing rats were infected with a replication-deficient human type 5 adenovirus containing cDNA for SOD2. An otherwise identical virus that contained no cDNA was used as a control (Adnull). Hypoxic Adnull rats had decreased rates of AFR (0.12 +/- 0.1 ml/h) as compared with hypoxic AdSOD2 and normoxic control rats (0.47 +/- 0.04 ml/h and 0.49 +/- 0.02 ml/h, respectively), with parallel changes in Na,K-ATPase.


Asunto(s)
Adenoviridae/genética , Líquido del Lavado Bronquioalveolar/virología , Hipoxia de la Célula/fisiología , Alveolos Pulmonares/fisiología , Receptores Adrenérgicos beta/fisiología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Superóxido Dismutasa/genética , Animales , Regulación Enzimológica de la Expresión Génica , Regulación Viral de la Expresión Génica , Oxígeno , Presión Parcial , Edema Pulmonar/prevención & control , Ratas
4.
Proc Natl Acad Sci U S A ; 103(12): 4604-9, 2006 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-16537427

RESUMEN

The molecular mechanisms of pulmonary fibrosis are poorly understood. Previous reports indicate that activation of TGF-beta1 is essential for the development of pulmonary fibrosis. Here, we report that the proapoptotic Bcl-2 family member Bid is required for the development of pulmonary fibrosis after the intratracheal instillation of bleomycin. Mice lacking Bid exhibited significantly less pulmonary fibrosis in response to bleomycin compared with WT mice. The attenuation in pulmonary fibrosis was observed despite similar levels of inflammation, lung injury, and active TGF-beta1 in bronchoalveolar lavage fluid 5 days after the administration of bleomycin in mice lacking Bid and in WT controls. Bleomycin induced similar levels cell death in vitro in alveolar epithelial cells isolated from WT and bid(-/-) mice. By contrast, alveolar epithelial cells from bid(-/-) mice were resistant to TGF-beta1-induced cell death. These results indicate that Bcl-2 family members are critical regulators for the development of pulmonary fibrosis downstream of TGF-beta1 activation.


Asunto(s)
Proteína Proapoptótica que Interacciona Mediante Dominios BH3/genética , Fibrosis Pulmonar/genética , Factor de Crecimiento Transformador beta/metabolismo , Animales , Apoptosis/genética , Bleomicina/toxicidad , Líquido del Lavado Bronquioalveolar/química , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Fibroblastos/efectos de los fármacos , Fibroblastos/patología , Pulmón/efectos de los fármacos , Pulmón/patología , Ratones , Ratones Mutantes , Fibrosis Pulmonar/inducido químicamente , Fibrosis Pulmonar/patología , Factor de Crecimiento Transformador beta/análisis , Factor de Crecimiento Transformador beta/farmacología , Factor de Crecimiento Transformador beta1
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA